EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access · CC BY 4.0

Targeting osteoarthritis with small extracellular vesicle therapy: potential and perspectives

Alba González-Rodríguez, F Javier De Toro, Alberto Jorge-Mora, Pablo Fernandez-Pernas, Carlota Probaos Rivadulla, María Fraga, Juan A Fafián-Labora, María C Arufe

Frontiers in Bioengineering and Biotechnology · 20.06.2025 · 13

DOI: 10.3389/fbioe.2025.1570526 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Frontiers in Bioengineering and Biotechnology, online erschienen am 20.06.2025. Verfasst von Alba González-Rodríguez und 7 weiteren Autor:innen. Beteiligte Einrichtung: Servicio de Cirugía Plástica, Complexo Hospitalario Universitario de A Coruña (CHUAC), A Coruña, Spain. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 162 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Osteoarthritis (OA) is a degenerative joint disease marked by inflammation, cartilage degradation, and pain, leading to a significant decline in quality of life. Recent advancements in extracellular vesicle (EV) research have introduced new therapeutic possibilities, with small extracellular vesicles (sEV) emerging as a promising strategy for OA treatment. sEV, particularly those derived from mesenchymal stem cells (MSCs), synoviocytes, chondrocytes, and induced pluripotent stem cells (iPSCs), demonstrate substantial anti-inflammatory and regenerative properties. These nanosized vesicles facilitate intercellular communication, delivering bioactive molecules that can modulate the joint microenvironment, promote chondrogenesis, and alleviate pain. Preclinical and early clinical studies indicate that sEV-based therapies may slow disease progression and enhance cartilage repair in OA patients. Despite the promising potential, challenges remain, including standardizing isolation techniques, understanding underlying mechanisms, and navigating regulatory pathways. This systematic review analyzes relevant publications published between 2019 and 2025, highlighting the therapeutic and biomarker potential of sEV in OA. Although there is substantial ongoing research into sEV and biomarkers, the fundamental understanding of OA pathogenesis remains largely unchanged, with most studies continuing to focus on established mechanisms of cartilage degradation, inflammation, and subchondral bone changes. The findings suggest that while therapeutic research into sEV is progressing, advancements in unraveling new pathophysiological mechanisms of OA are more limited. Further research is essential to optimize therapeutic protocols and establish clinical efficacy, marking sEV-based therapies as a promising but evolving approach for OA treatment.

Schlagwörter

Stichwörter der Autor:innen

biomarkerosteoarthiritispersonalized medicinesmall extracelllular vesiclestherapy

Autor:innen und Institutionen

  • Servicio de Cirugía Plástica, Complexo Hospitalario Universitario de A Coruña (CHUAC), A Coruña, Spain.
  • Grupo de Terapia Celular Medicina, Instituto de Investigación Biomédica de A Coruña (INIBIC), Complexo Hospitalario Universitario de A Coruña (CHUAC), Sergas/ Universidade da Coruña (UDC), As Xubías, A Coruña, Spain.
  • CICA - Centro Interdisciplinar de Química e Bioloxía e, Departamento de Bioloxía, Facultade de Ciencias, Universidade da Coruña (UDC), Campus de Elviña, CICA, A Coruña, Spain.
  • Departamento de Fisioterapia, Medicina y Ciencias Biomédicas, Facultad de Ciencias de la Salud, Universidade da Coruña (UDC), Campus de Elviña, CICA, A Coruña, Spain.
  • Cirugíía Ortopédica y Traumatología / Complejo Hospitalario de A Coruña, A Coruña, Spain.
  • Centre of Biological Sciences, University of Veterinary Medicine of Vienna, Vienna, Austria.

Zitieren

APA

González-Rodríguez, A., De Toro, F. J., Jorge-Mora, A., Fernandez-Pernas, P., Rivadulla, C. P., Fraga, M., Fafián-Labora, J. A., & Arufe, M. C. (2025). Targeting osteoarthritis with small extracellular vesicle therapy: potential and perspectives. Frontiers in Bioengineering and Biotechnology, 13. https://doi.org/10.3389/fbioe.2025.1570526

Vancouver

González-Rodríguez A, De Toro FJ, Jorge-Mora A, Fernandez-Pernas P, Rivadulla CP, Fraga M, et al. Targeting osteoarthritis with small extracellular vesicle therapy: potential and perspectives. Frontiers in Bioengineering and Biotechnology. 2025;13. doi:10.3389/fbioe.2025.1570526

BibTeX
@article{GonzlezRodrguez2025,
  author = {González-Rodríguez, Alba and De Toro, F Javier and Jorge-Mora, Alberto and Fernandez-Pernas, Pablo and Rivadulla, Carlota Probaos and Fraga, María and Fafián-Labora, Juan A and Arufe, María C},
  title = {Targeting osteoarthritis with small extracellular vesicle therapy: potential and perspectives},
  journal = {Frontiers in Bioengineering and Biotechnology},
  year = {2025},
  volume = {13},
  doi = {10.3389/fbioe.2025.1570526}
}
Kostenlos starten →